Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Karuna Therapeutics, Inc. | krtx-ex312_9.htm |
| EX-31.1 - EX-31.1 - Karuna Therapeutics, Inc. | krtx-ex311_12.htm |
| EX-23.1 - EX-23.1 - Karuna Therapeutics, Inc. | krtx-ex231_7.htm |
| 10-K - 10-K - Karuna Therapeutics, Inc. | krtx-10k_20201231.htm |
Exhibit 32.1
CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL
FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 10-K of Karuna Therapeutics, Inc. (the “Company”) for the fiscal year ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his or her knowledge:
|
|
1. |
the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
2. |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: February 25, 2021
|
/s/ Steven Paul |
|
Steven Paul, M.D. |
|
Chief Executive Officer, President and Chairman |
|
(Principal Executive Officer) |
|
|
|
/s/ Troy Ignelzi |
|
Troy Ignelzi |
|
Chief Financial Officer |
|
(Principal Financial and Accounting Officer) |